Opti-Med, FDA debate stability and validation interpretations for OTCs. (Human Drugs).(over-the-counter drugs): An article from: Inspection Monitor

This digital document is an article from Inspection Monitor, published by Washington Information Source on August 1, 2002. The length of the article is 1042 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Opti-Med, FDA debate stability and validation interpretations for OTCs. (Human Drugs).(over-the-counter drugs)
Publication:Inspection Monitor (Newsletter)
Date: August 1, 2002
Publisher: Washington Information Source
Volume: 7 Issue: 8 Page: NA

Distributed by Thomson Gale